Skip to main content

GG 771 Pill - white round, 8mm

Pill with imprint GG 771 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Sandoz Pharmaceuticals Inc.

Glipizide is used in the treatment of Type 2 Diabetes and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 771

Glipizide 5 mg GG 771
Glipizide 5 mg GG 771 Front
Glipizide 5 mg GG 771 Back
Glipizide 5 mg GG 771 Front
Glipizide 5 mg GG 771 Back
Glipizide 5 mg GG 771

Glipizide

Imprint
GG 771
Strength
5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, silicon dioxide, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00781-1452 (Discontinued) Sandoz Inc.
00832-0491 (Discontinued) Upsher-Smith Laboratories Inc.
00904-6124 (Discontinued) Major Pharmaceuticals
54569-3841 (Discontinued) A-S Medication Solutions, LLC (repackager)
66267-0100 (Discontinued) Nucare Pharmaceuticals Inc. (repackager)
67544-0302 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.